HDAC Inhibitors Clinical Trial Pipeline Shows Remarkable Momentum with 40+ Pharma Companies Advancing Research
The clinical development field for histone deacetylase (HDAC) inhibitors continues to demonstrate significant momentum as of March 2026, with more...
